贝伐单抗辅助治疗临床研究带来的思考
摘要
结直肠癌是常见的恶性肿瘤之一,其发病率和死亡率均居前列。Ⅲ期和部分Ⅱ期患者主要治疗方法是根治性手术切除随后辅助化疗,1990年代确立了以5-Fu为主的化疗为标准辅助化疗方案。
出处
《实用肿瘤杂志》
CAS
2013年第2期119-123,共5页
Journal of Practical Oncology
参考文献25
-
1Sargent D,Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer:observations based on individual patient data from 20, 898 patients on 15 randomized trials [ J ]. J Clin Oncol, 2009,27 ( 6 ) : 872 - 877.
-
2Graham JS, Cassidy J. Adjuvant therapy in colon cancer [J]. Expert Rev Anticancer Ther, 2012, 12 ( 1 ) : 99 - 109.
-
3Jenab-Wolcott J, Giantonio BJ. Antiangiogenic therapy in colorectal cancer:where are we 5 years later [ J] ? Clin Colorectal Cancer, 2010,9 ( Suppl 1 ) : S7 - S15.
-
4Welch S, Spithoff K, Rumble RB, et al. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review [ J ]. Ann Oncol, 2010,21 (6) : 1152 - 1162.
-
5Allegra CJ,Yothers G, O'Connell MJ,et al. Phase m trial assessing bevacizumab in stages Ⅱ and Ⅲ carcinoma of the colon: results of NSABP protocol C-08 [J]. J Clin Oncol,2011,29(1 ) :11 - 16.
-
6De Gramont A, Van Cutsem E, Schmoll HJ, et al. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT) :a phase 3 randomised controlled trial [J]. Lancet Oncol, 2012,13(12) :1225 - 1233.
-
7Ellis LM, Hicklin DJ. VEGF-targeted therapy : mechanisms of anti-turnout activity [ J ]. Nat Rev Cancer,2008,8 ( 8 ) : 579 - 591.
-
8Bagri A, Berry L, Gunter B, et al. Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy [J]. Clin Cancer Res,2010,16(15) : 3887 - 3900.
-
9Ocana A, Amir E, Vera F, et al. Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions [J]. J Clin Oncol,2011, 29 (3) :254 - 256.
-
10Norton L. Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy [J]. Oneologist ,2005,10(6) :370 - 381.
-
1邵国光,郭晔,王星星,张宏,崔有斌,梁婷婷,马克威.110例N1期食管鳞癌术后辅助治疗疗效分析[J].中华肿瘤杂志,2016,38(1):55-62. 被引量:3
-
2毕清,任宏轩,田青,赵明利,鲍明亮.新辅助化疗周期数对Ⅲ期乳腺癌预后的影响[J].中国误诊学杂志,2011,11(18):4381-4382. 被引量:2
-
3于兰,程丕叶,徐燕,王栾秋.调强放疗联合替吉奥和顺铂新辅助治疗局部进展期胃癌临床研究[J].肿瘤研究与临床,2016,28(11):739-742. 被引量:6
-
4解亦斌,王成锋,李忱瑞,单毅,赵东兵,田艳涛,赵平.胰体尾癌辅助治疗对患者生存的影响[J].中华医学杂志,2009,89(14):951-954. 被引量:1
-
5杜春燕,师英强.胃肠道间质瘤新辅助治疗进展[J].肿瘤研究与临床,2007,19(1):1-4. 被引量:2
-
6李敏,徐川,刘璇.华蟾素辅助治疗中晚期非小细胞肺癌临床疗效分析[J].肿瘤,2007,27(8):666-668. 被引量:11
-
7张勇,彭正,陈凛.胃癌新辅助化疗后病理完全缓解病例生存分析[J].中华医学杂志,2016,96(20):1582-1584. 被引量:21
-
8段晶晶,孔为民.早期宫颈癌术后辅助治疗的研究进展[J].中国医师杂志,2015,17(9):1429-1432. 被引量:1
-
9王妍,王志明,刘天舒.胃癌化疗的新视角[J].胃肠病学,2009,14(3):188-190. 被引量:3
-
10吕柯,宋展,王新伟.局灶进展性胃癌术前与术后行以多西紫杉醇为基础的辅助化疗比较[J].中国普通外科杂志,2014,23(4):417-420. 被引量:7